Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody
Fatih Arslan, Mirjam B. Smeets, Luke O'neill, Brian Keogh, Peter McGuirk, Leo Timmers, Claudia Tersteeg, Imo E. Hoefer, Pieter A. Doevendans, Gerard Pasterkamp, Dominique P.V. de Kleijn (2009). Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody. Circulation, 121(1), pp. 80-90, DOI: 10.1161/circulationaha.109.880187.
